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Abstract
Objectives—To compare the prevalence of cognitive, neurological, and behavioral outcomes at 
10 years of age in 428 girls and 446 boys who were born extremely preterm (EP).
Study design—889 of 966 eligible children previously enrolled in the multi-center Extremely 
Low Gestational Age Newborns (ELGAN) Study from 2002–2004 were evaluated at 10 years of 
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age. Children underwent a neuropsychological battery and testing for autism spectrum disorder 
(ASD), and parents reported on their child’s behavior, development, and seizures.
Results—28% of boys and 21% of girls exhibited moderate to severe impairment on summary 
measures of cognitive abilities. Boys had a higher prevalence of impairment than girls in nearly all 
measures of cognition, were more than twice as likely to have microcephaly (15% in boys, 8% in 
girls), and require more often assistive devices to ambulate (6% in boys, 4% in girls). In contrast, 
boys and girls had comparable risk for a history of seizure (identified in 10% of the cohort) or 
epilepsy (identified in 7% of the cohort). The boy-to-girl ratio of ASD (9% in boys, 5% in girls) 
was lower than expected compared with the overall US autism population.
Conclusion—In this contemporary cohort of children born extremely premature and evaluated at 
school age, boys had higher prevalence of cognitive, neurological, and behavioral deficits than 
girls. The ratio of boys to girls among those with ASD deserves further study as does the perinatal 
environmental- genetic interactions that might contribute to male preponderance of deficits in this 
high-risk sample.
Compared with term-born peers, children born extremely premature (EP) are at greatly 
increased risk for cognitive, behavioral, and neurological disabilities.(1–4) Among EP 
children, follow-up studies in early childhood report higher rates of neurological and early 
cognitive impairment in boys compared with girls.(5–14). Some of this increase in risk may 
be attributable to higher rates of neonatal morbidities among boys.(15)
Although many studies provide evidence for a male disadvantage on early 
neurodevelopmental assessments among children born EP, only a few large, epidemiological 
studies of children born EP after the early 1990s, in the era of routine surfactant and 
antenatal steroid use, have assessed cognitive outcomes in later childhood (7–12 years old) 
or adolescence. In a United Kingdom cohort of 11-year-old EP children, boys had lower 
scores than girls on assessments of cognition and reading achievement.(16, 17) In addition, 
boys were more likely than girls to have cerebral palsy, special education needs, and autism 
spectrum disorders (ASD). Neither a study of 219 extremely low birth weight children (< 
1000 grams) born in the United States between 1992 and 1995 in which 8-year-old children 
had a mean IQ score 10 points lower than those of term-born controls(18), nor a study of 
154 children born EP in Germany in which one-quarter of the children had intellectual 
disability at age 8 years, reported important sex-related differences in outcome. (19) 
Moreover, a recent meta-analysis of studies published through 2014 reported that the greater 
severity of neurocognitive deficits among boys in early childhood appears to ameliorate after 
age 5.(20) Our epidemiological study examined the school-age cognitive, behavioral, and 
neurological outcomes of EP boys compared with those of EP girls to verify this trend. This 
comparison is especially important in light of recently-reported reductions in the prevalence 
of cognitive and neurological disability in those born EP.(9) Here we compare the prevalence 
of dysfunctions among 428 EP girls and 446 EP boys born from 2002 to 2004 on a wide 
spectrum of cognitive, neurological, and behavioral outcomes, including intelligence 
quotient (IQ), executive function (EF), language ability, epilepsy, motor impairment, 
microcephaly, and ASD.
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Methods
The Extremely Low Gestational Age Newborns (ELGAN) Study is a national, multicenter, 
observational study of the risk of structural and functional neurological disorders in 
extremely preterm infants.(21) During the years 2002–2004, women delivering before 28 
weeks gestation were asked to enroll in the study. 1249 mothers of 1506 infants consented to 
participate. Of 1200 ELGAN Study survivors, 1102 (92%) were evaluated at age 2 years. At 
10 years of age, 966 surviving children, on whom blood specimens were collected in the first 
weeks of life for assessment of inflammation-related proteins, were recruited. The families 
of 889 (92%) of these children returned for follow up and 874 children were assessed on 
cognitive, neurological, and behavioral outcomes. The institutional review boards of all 
participating institutions approved enrollment and consent procedures for this follow-up 
study.
Families willing to participate were scheduled for one visit, usually at the institution of birth. 
The cognitive evaluations were administered by certified child psychologists in a 3- to 4-
hour session that included breaks. All psychologist examiners underwent a 1-day in-person 
training and verification of competency for administering the neurocognitive test battery. 
Further, all evaluators for ASD participated in research-level training in the administration 
and scoring of the Autism Diagnostic Interview - Revised (ADI-R) and Autism Diagnostic 
Observation Schedule-2 (ADOS) and established inter-rater reliability with the study autism 
expert (R.M.J.). Parent and child measures were selected to provide the most comprehensive 
assessment possible in one 3–4 hour testing session, with the exception of children who 
screened positive for ASD, who returned for a second visit.
The goal was to assess children’s abilities in a number of key domains, some of which were 
assessable by direct examination of the child, and others were provided by the parent (and 
teacher). The direct assessments reported in this manuscript evaluated general cognitive 
ability, language ability, EF, aspects of ASD, and presence of seizure or epilepsy.
General cognitive ability (or IQ) was assessed with the School-Age Differential Ability 
Scales–II (DAS-II[22]) Verbal and Nonverbal Reasoning scales.
Expressive and receptive language skills were evaluated with the Oral and Written Language 
Scales (OWLS [23]), which assesses semantic, morphological, syntactic, and pragmatic 
production and comprehension of elaborated sentences.
Attention and executive function were assessed with the DAS-II and the 
NEuroPSYchological Assessment (NEPSY-II).(24) DAS-II Recall of Digits Backward and 
Recall of Sequential Order measured verbal working memory. NEPSY-II Auditory Attention 
and Auditory Response Set measured sustained auditory attention, set switching and 
inhibition. NEPSY-II Inhibition-Inhibition and Inhibition-Switching measured simple 
inhibition and inhibition in the context of set shifting, respectively. NEPSY-II Animal 
Sorting measured visual concept formation and mental flexibility.
Using latent profile analysis (LPA) to find EP children with similar distinctive profiles on 
measures of cognitive and executive functioning, we identified four subgroups 
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corresponding to functioning that was normal (34% of cohort), low-normal (41%), 
moderately impaired (17%), and severely impaired (8%).
Identification of seizures involved a two-stage process.(25) First, a “yes” answer to any of 
11 broad questions for history of possible seizures prompted the expert pediatric 
epileptologist to conduct a structured interview followed by an open-ended interview, and 
then to determine whether a reported event was a seizure. A second epileptologist 
independently reviewed interview responses and similarly rated the event type. When the 
two physicians’ disagreed on the presence of seizures, which occurred in 3% of the children 
whose parent was interviewed, a third epileptologist reviewed the interview responses and 
made the final determination as to whether or not a seizure had occurred. For these analyses, 
we defined epilepsy as having 2 or more seizures unassociated with fever or other 
provocation.
After undergoing initial training, a research assistant rated each child on the Gross Motor 
Function Classification System (GMFCS). A level of 0 indicates normal motor function 
without limitation. A level of 1 or 2 indicates that the child can walk independently with 
limitations, but does not require assistive mobility devices, whereas children with a level of 
≥ 3 require such devices.(26)
The head circumference was measured as the largest possible occipital- frontal 
circumference. Measurements were rounded to the closest 0.1 centimeter. All head 
circumferences are presented as Z-scores.(27)
All children were screened by parent report with the Social Communication Questionnaire 
(SCQ) for risk of ASD. Children determined to be at risk on the SCQ, were assessed with 
the Autism Diagnostic Interview – Revised (ADI-R), an in-depth parent interview. Children 
meeting ADI-R criteria for ASD were administered the Autism Diagnostic Observation 
Schedule-2 (ADOS-2). Children meeting standardized research criteria for ASD on both the 
ADI-R and ADOS-2 were classified as having ASD.
Statistical Analyses
To compare the distribution of neurocognitive test scores among boys and girls born EP with 
the expected distribution for the normal population, test scores were re-expressed as Z-
scores using normative means and standard deviations (SD). For a normally-distributed 
population, 2.3% of children would be expected to have Z-scores at or below −2, and 13.6% 
to have Z-scores greater than −2 and less than or equal to −1. Adjusted odds ratios (OR) and 
95% confidence intervals (CI) comparing boys to girls on the likelihood of having a test 
score more than 2 SD below the normative mean were calculated using multivariable logistic 
regression (multivariable multinomial logistic regression for the LPA classification) 
adjusting for variables that are associated both with outcome and preterm birth: maternal 
age, race, education, insurance status, and child gestational age, and birth weight Z-score. 
Parents of 48 children out of the 315 who screened positive for possible seizures did not 
complete the seizure interviews with the epileptologist. Inverse probability weighting was 
used to account for these missing data in estimating seizure prevalence.
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Results
Boys were less likely than girls to be growth restricted, and more likely than girls to be born 
at earlier gestational age (Table I). At age 2 years, boys were more likely than girls to have a 
Mental Development Index or a Psychomotor Development Index (Bayley Scales of Infant 
Development-II) more than 3 SD below the normative mean (<55).(1)
Distribution of verbal and nonverbal IQ (DAS-II) and NEPSY-II
For both girls and boys, the distributions of DAS-II and NEPSY-II scores were shifted to 
lower values compared with the expected normal distribution (horizontal lines at 0, 1, and −1 
on the vertical scale indicate values at the mean and 1 SD above and below the population 
mean, respectively) (Figure 1). Boys had lower scores than girls across all neurocognitive 
tests, including DAS verbal and nonverbal IQ, and language, working memory, and 
executive function measures.
Distribution of DAS and other neuropsychological measures by sex
Z-scores (ie, the number of standard deviations above or below the normative mean) of −2 or 
more are expected 2.3% of the time in the normal population. The distribution of almost 
every assessment is shifted toward lower scores, with scores 2 or more SD below the normal 
population mean occurring in 12 to 36% of the sample, in contrast to the expected 2.3%, and 
scores 1 to 2 SD below the mean occurring in 14 to 31%, in contrast to the expected 13.6%. 
On most neurocognitive tests, boys had lower scores than girls. The most prominent sex 
differences were found in the proportion of children who had abilities more than 2 SD below 
the mean on DAS-II Verbal Reasoning Ability (12% of girls v. 22% of boys) and OWLS 
Listening Comprehension (13% of girls v. 24% of boys) (Table 2).
Summary IQ-executive function classification, neurobehavioral and 
neurological outcomes
With LPA classification as the outcome, a multivariable multinomial logistic regression 
analysis that adjusted for mother's age, race, education, insurance status, and child's 
gestational age and birth weight Z-score found boys were twice as likely as girls to be 
classified as severely impaired (OR: 2.1; 95% CI:1.2, 3.8), and 1.8 times more likely than 
girls to be classified as moderately impaired (95% CI:1.1, 2.7) (Table 3).
Boys were more than twice as likely as girls to meet diagnostic criteria for ASD (OR: 2.0; 
95% CI 1.1, 3.6), identified in 7% of the cohort. Also, boys had a 50% greater risk than girls 
for mild limitations in gross motor function (OR: 1.6; 95% CI 1.2, 2.3), identified in nearly 
one quarter of the cohort. Furthermore, boys were two times more likely than girls to be 
unable to ambulate independently without assistive devices (OR: 2.1; 95% CI 1.1, 4.0), seen 
in 5% of the cohort. Also, boys were more than twice as likely as girls to have microcephaly 
at age 10 (OR: 2.4; 95% CI 1.5, 4.0), identified in 11.9% of the cohort. The greater number 
of boys with microcephaly and gross motor impairment remained even when children 
identified to have cerebral palsy at age 2 years were excluded (data not shown). On the other 
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hand, boys and girls had the same rates of seizures and epilepsy, identified in 10% and 7% 
of the cohort, respectively.
Discussion
In this report of cognitive, behavioral, and neurological outcomes of school-age children 
born EP, we found that a quarter of the children (28% of boys and 21% of girls) exhibited 
moderate to severe impairment on summary measures of cognitive abilities. Impairment was 
more prevalent among boys for nearly all measures of cognition,(28–30) even after 
adjustment for socio-economic indicators, gestational age, and birth weight Z-score. 
Furthermore, boys were more than twice as likely to have microcephaly, and to be unable to 
ambulate without assistive devices. However, boys were not at increased risk for developing 
a seizure or epilepsy before age 10. The approximately 2:1 boy-girl ratio among those with 
ASD in our cohort is lower than has been described in unselected samples from mainly 
term-born populations.(31)
Our data confirm the few other recent large, epidemiological studies that children born EP 
have an excessive burden of cognitive deficits in later childhood (7–12 years old),(16, 18, 
19) and only the Epicure Study found a sex discrepancy with 49% of boys and 30% of girls 
having moderate to severe cognitive impairment.(16) We confirm that the excessive burden 
of cognitive deficits reported in boys in early childhood (5–10, 14, 18, 32) also is evident in 
later childhood. The excess of neurocognitive deficit seen in boys at age 10, evident across 
nearly all individual and summary neurocognitive test scores, does not support the finding in 
a study of children born at less than 32 weeks gestation that the cognitive disparity between 
boys and girls in early childhood is ameliorated after 5 years of age.(20) On the other hand, 
within the narrow frame of 24 to 28 weeks, our multivariate analyses affirm findings of 
others that gestational age does not account fully for the outcome differences seen between 
boys and girls.(5)
One explanation for the observed sex differences is that preterm birth may disrupt hormonal 
signals such as the conversion of testosterone to estradiol,(33) and that higher circulating 
concentrations of testosterone in males may accentuate the deleterious consequences of early 
insults to brain, as reflected in measures of both neuropathology and behavior.(34) Another 
possibility is that EP boys and girls differ in their rates of brain maturation,(35) as has been 
observed among children born at term, resulting in differences in vulnerability or resilience 
to insults. For example, genetic control of critical neurotransmitter development, such as 
dopamine, appears to differ in boys and girls, and may predispose to greater disease risk in 
boys.(36) Boys and girls also appear to differ in their response to stimuli that lead to 
excessive neuronal loss related to dysregulated apoptosis.(37, 38)
Three lines of evidence support the validity of our finding that boys have modestly increased 
risks in neurodevelopmental morbidities. First, a number of published studies describe 
similar modest increase in risk of morbidities among boys.(5–10, 14, 18) Second, the higher 
risks among boys persisted after adjustment for confounders, including gestational age, 
which is an effective proxy for unmeasured indicators of vulnerability among individuals 
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born extremely premature.(39) Finally, sex differences were found across several 
neurological domains, decreasing the likelihood that our findings are attributable to chance.
We found that compared with girls, boys are more likely to be microcephalic and to have 
motor impairment, a finding that we identified also in this cohort at age 2 years even after 
excluding children with cerebral palsy from the analyses (Data not shown). Although 
cerebral palsy occurs more often in boys(40), and microcephaly and gross motor abilities are 
correlates of cerebral palsy, we are not aware of previous reports that identify microcephaly 
or gross motor function abnormalities that affect boys more than girls in the absence of 
cerebral palsy. Our observations indicate that the neurological disadvantages boys 
experience encompass broad structural (ultrasound, microcephaly) and functional (cognition 
and motor) domains.
On the other hand, the risk of postnatal seizures and epilepsy in boys and girls is comparable 
in our cohort. This observation is surprising given that compared with girls, boys are more 
likely to have motor impairment, ASD, and cognitive disabilities, all of which are associated 
with an elevated risk of having seizures and epilepsy. The vulnerability of premature brains 
to ultimately develop epilepsy is complex and may involve age-related interplay among the 
influences of predisposing brain injury, sex hormone status and cellular excitability.(41) 
Although boys may be at greater risk of structural brain injury, the cellular mechanisms that 
underlie seizures or epilepsy may be less sex-specific, and may involve inflammatory, 
genetic, and epigenetic mechanisms.(41, 42) The similar male/female prevalence rates of 
seizures and epilepsy in our ELGAN cohort, though unexpected, afford an opportunity to 
explore the relationship between prematurity and neuronal excitability.
Compared with the general population, the rate of ASD in children born EP is approximately 
20 times higher in girls and about 9 times higher in boys. Overall in our cohort, boys had a 
2-fold increased risk of ASD compared with girls, which stands in contrast to the 4-fold 
increased risk for autism among boys in the general population (43, 44). We consider three 
explanations for a lower male-female ratio among children born EP. First, emerging data 
suggest that the autism phenotype in girls, with a larger proportion of higher functioning 
girls, may be less likely to be diagnosed in community-based epidemiological studies in 
early years of life.(31) This could explain the observation in some studies that the ratio of 
boys to girls is about 4 at younger ages, but rises closer to 2 in late childhood and 
beyond.(45–47)
Second, the decreased sex ratio in children born EP may reflect differences in risk factors for 
ASD compared with the general ASD population, including the possibility that factors, 
which protect girls born at term, are not present among those born EP. Third, the impact of 
environmental-inflammatory-gene interactions, associated with EP, might not be sex-
specific.(48–52)
As a final point, the autism identified in children born EP may differ from that found in the 
general population because of the higher rates of sensorimotor and intellectual disability.(53) 
The prevalence of intellectual disability or sensorimotor impairment in our cohort, however, 
did not differ substantially from rates seen among autistic children in the general population 
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(manuscript in preparation). Consequently, the autism we have identified in EP children 
using “gold-standard” instruments appears very similar to autism in the general population.
The strengths of this study include the large number of children who were born at an 
extremely low gestational age and followed until age 10 years, the relatively low rate of loss 
to follow-up, and the range of neurological and neurocognitive dysfunctions identified using 
well-validated tools for assessment. Additionally, the cohort represents a broad, unbiased 
sampling of children living in several regions of the country with diverse socioeconomic, 
racial, and ethnic characteristics, which make the findings generalizable to most children 
born EP. One limitation is that we did not evaluate term-born control children, but rather 
compared the distribution of cognitive outcomes in our cohort with standardized population-
based normative means and standard deviations. Although population norms may change 
over time (Flynn effect)(54), such drift is most often towards higher scores on standardized 
tests of cognition. Thus, the magnitude of differences seen in our cohort is unlikely 
explained by modest drift in normative test performance. Finally, as with all observational 
studies, we are limited in our ability to infer causation or pathways from associations. 
Regardless, our findings have implications for research on the relationship of perinatal 
environmental-genetic interactions and cognitive and behavioral outcome.
Acknowledgments
We acknowledge the contributions of the subjects and their families.
Supported by the National Institute of Neurological Disorders and Stroke (5U01NS040069-05 and 
2R01NS040069-09). Center grant award from the National Institute of Child Health and Human Development 
(5P30HD018655-28).
Abbreviations used
EP Extremely premature
IQ Intelligent quotient
ASD Autism spectrum disorder
ELGAN Extremely low gestational age newborn
ADI-R Autism Diagnostic Interview – Revised
ADOS Autism Diagnostic Observation Schedule-2
EF Executive function
DAS-II Differential Ability Scales–II
OWLS Oral and Written Language Scales
NEPSY-II NEuroPSYchological Assessment-II
LPA Latent profile analysis
GMFCS Gross Motor Function Classification System
SCQ Social Communication Questionnaire
Kuban et al. Page 8
J Pediatr. Author manuscript; available in PMC 2017 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
SD Standard deviation
Citations
1. O'Shea TM, Allred EN, Kuban KC, Dammann O, Paneth N, Fichorova R, et al. Elevated 
concentrations of inflammation-related proteins in postnatal blood predict severe developmental 
delay at 2 years of age in extremely preterm infants. J Pediatr. 2012; 160:395–401. e4. [PubMed: 
22000304] 
2. Leviton A, Kuban KC, Allred EN, Fichorova RN, O'Shea TM, Paneth N, et al. Early postnatal blood 
concentrations of inflammation-related proteins and microcephaly two years later in infants born 
before the 28th post-menstrual week. Early Hum Dev. 2011; 87:325–330. [PubMed: 21334149] 
3. Kuban KCK, O'Shea TM, Alled EN, Paneth N, Hirtz D, Fichorova RN, Leviton A. Systemic 
inflammation and cerebral palsy risk in extremely preterm infants. Journal of Child Neurology. 
2014; 29:1692–1698. [PubMed: 24646503] 
4. O'Shea TM, Joseph RM, Kuban KC, Allred EN, Ware J, Coster T, et al. Elevated blood levels of 
inflammation-related proteins are associated with an attention problem at age 24 mo in extremely 
preterm infants. Pediatr Res. 2014; 75:781–787. [PubMed: 24614800] 
5. Peacock JL, Marston L, Marlow N, Calvert SA, Greenough A. Neonatal and infant outcome in boys 
and girls born very prematurely. Pediatr Res. 2012; 71:305–310. [PubMed: 22258087] 
6. Skiold B, Alexandrou G, Padilla N, Blennow M, Vollmer B, Aden U. Sex differences in outcome 
and associations with neonatal brain morphology in extremely preterm children. J Pediatr. 2014; 
164:1012–1018. [PubMed: 24530122] 
7. Kent AL, Wright IM, Abdel-Latif ME, New South W. Australian Capital Territory Neonatal 
Intensive Care Units Audit G. Mortality and adverse neurologic outcomes are greater in preterm 
male infants. Pediatrics. 2012; 129:124–131. [PubMed: 22184652] 
8. Johnson S, Fawke J, Hennessy E, Rowell V, Thomas S, Wolke D, et al. Neurodevelopmental 
disability through 11 years of age in children born before 26 weeks of gestation. Pediatrics. 2009; 
124:e249–e257. [PubMed: 19651566] 
9. Moore T, Hennessy EM, Myles J, Johnson SJ, Draper ES, Costeloe KL, et al. Neurological and 
developmental outcome in extremely preterm children born in England in 1995 and 2006: the 
EPICure studies. BMJ. 2012; 345:e7961. [PubMed: 23212880] 
10. Frondas-Chauty A, Simon L, Branger B, Gascoin G, Flamant C, Ancel PY, et al. Early growth and 
neurodevelopmental outcome in very preterm infants: impact of gender. Arch Dis Child Fetal 
Neonatal Ed. 2014; 99:F366–F372. [PubMed: 24916576] 
11. Farooqi A, Hagglof B, Sedin G, Serenius F. Impact at age 11 years of major neonatal morbidities in 
children born extremely preterm. Pediatrics. 2011; 127:e1247–e1257. [PubMed: 21482612] 
12. Mansson J, Fellman V, Stjernqvist K, Group ES. Extremely preterm birth affects boys more and 
socio-economic and neonatal variables pose sex-specific risks. Acta Paediatr. 2015; 104:514–521. 
[PubMed: 25620552] 
13. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR. Neurologic and developmental 
disability after extremely preterm birth. EPICure Study Group. N Engl J Med. 2000; 343:378–384. 
[PubMed: 10933736] 
14. Hintz SR, Kendrick DE, Vohr BR, Poole WK, Higgins RD. Changes in neurodevelopmental 
outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age 
born in 1993–1999. Pediatrics. 2005; 115:1645–1651. [PubMed: 15930228] 
15. Stevenson DK, Verter J, Fanaroff AA, Oh W, Ehrenkranz RA, Shankaran S, et al. Sex differences 
in outcomes of very low birthweight infants: the newborn male disadvantage. Arch Dis Child Fetal 
Neonatal Ed. 2000; 83:F182–F185. [PubMed: 11040165] 
16. Johnson S, Hennessy E, Smith R, Trikic R, Wolke D, Marlow N. Academic attainment and special 
educational needs in extremely preterm children at 11 years of age: the EPICure study. Arch Dis 
Child Fetal Neonatal Ed. 2009; 94:F283–F289. [PubMed: 19282336] 
Kuban et al. Page 9
J Pediatr. Author manuscript; available in PMC 2017 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
17. Johnson S, Hollis C, Kochhar P, Hennessy E, Wolke D, Marlow N. Psychiatric disorders in 
extremely preterm children: longitudinal finding at age 11 years in the EPICure study. J Am Acad 
Child Adolesc Psychiatry. 2010; 49:453–463. e1. [PubMed: 20431465] 
18. Taylor HG, Klein N, Drotar D, Schluchter M, Hack M. Consequences and Risks of <1000-g Birth 
Weight for Neuropsychological Skills, Achievement, and Adaptive Functioning. Developmental 
and Behavioral Pediatrics. 2006; 27:459–469.
19. Stahlmann N, Rapp M, Herting E, Thyen U. Outcome of extremely premature infants at early 
school age: health-related quality of life and neurosensory, cognitive, and behavioral outcomes in a 
population-based sample in northern Germany. Neuropediatrics. 2009; 40:112–119. [PubMed: 
20020395] 
20. Linsell L, Malouf R, Morris J, Kurinczuk JJ, Marlow N. Prognostic Factors for Poor Cognitive 
Development in Children Born Very Preterm or With Very Low Birth Weight: A Systematic 
Review. JAMA Pediatr. 2015:1–11.
21. O'Shea TM, Allred EN, Dammann O, Hirtz D, Kuban KC, Paneth N, et al. The ELGAN study of 
the brain and related disorders in extremely low gestational age newborns. Early Hum Dev. 2009; 
85:719–725. [PubMed: 19765918] 
22. Elliott, CD. Differential ability scales. second. San Antonio, TX: The Psychological Corporation; 
2007. 
23. Carrow-Woolfolk, E. Oral and Written Language Skills: Written Expression Scale Manual. Circle 
Pines, MN: American Guidance Service; 1996. 
24. Korkman, M.; Kirk, U.; Kemp, S. NEPSY-second edition (NEPSY-II). San Antonio, Texas: The 
Psychological Corporation; 2007. 
25. Douglass LM, Kuban K, Tarquinio D, Schraga L, Jonas R, Heeren T, et al. A Novel Parent 
Questionnaire for the Detection of Seizures in Children. Pediatr Neurol. 2016; 54:64–69. 
[PubMed: 26552646] 
26. Palisano RJ, Rosenbaum P, Bartlett D, Livingston MH. Content validity of the expanded and 
revised Gross Motor Function Classification System. Dev Med Child Neurol. 2008; 50:744–750. 
[PubMed: 18834387] 
27. Roche AF, Mukherjee D, Guo SM, Moore WM. Head circumference reference data: birth to 18 
years. Pediatrics. 1987; 79:706–712. [PubMed: 3575026] 
28. Barabasi AL. The origin of bursts and heavy tails in human dynamics. Nature. 2005; 435:207–211. 
[PubMed: 15889093] 
29. Eguiluz VM, Zimmermann MG. Transmission of information and herd Behavior: an application to 
financial markets. Phys Rev Lett. 2000; 85:5659–5662. [PubMed: 11136071] 
30. Viswanathan GM, Buldyrev SV, Havlin S, da Luz MG, Raposo EP, Stanley HE. Optimizing the 
success of random searches. Nature. 1999; 401:911–914. [PubMed: 10553906] 
31. Lai MC, Lombardo MV, Auyeung B, Chakrabarti B, Baron-Cohen S. Sex/gender differences and 
autism: setting the scene for future research. J Am Acad Child Adolesc Psychiatry. 2015; 54:11–
24. [PubMed: 25524786] 
32. Streimish IG, Ehrenkranz RA, Allred EN, O'Shea TM, Kuban KC, Paneth N, et al. Birth weight- 
and fetal weight-growth restriction: impact on neurodevelopment. Early Hum Dev. 2012; 88:765–
771. [PubMed: 22732241] 
33. Crider A, Thakkar R, Ahmed AO, Pillai A. Dysregulation of estrogen receptor beta (ERbeta), 
aromatase (CYP19A1), and ER co-activators in the middle frontal gyrus of autism spectrum 
disorder subjects. Mol Autism. 2014; 5:46. [PubMed: 25221668] 
34. Hill CA, Threlkeld SW, Fitch RH. Early testosterone modulated sex differences in behavioral 
outcome following neonatal hypoxia ischemia in rats. Int J Dev Neurosci. 2011; 29:381–388. 
[PubMed: 21473905] 
35. De Bellis MD, Keshavan MS, Beers SR, Hall J, Frustaci K, Masalehdan A, et al. Sex differences in 
brain maturation during childhood and adolescence. Cereb Cortex. 2001; 11:552–557. [PubMed: 
11375916] 
36. Loke H, Harley V, Lee J. Biological factors underlying sex differences in neurological disorders. 
Int J Biochem Cell Biol. 2015; 65:139–150. [PubMed: 26028290] 
Kuban et al. Page 10
J Pediatr. Author manuscript; available in PMC 2017 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
37. Zhu C, Xu F, Wang X, Shibata M, Uchiyama Y, Blomgren K, et al. Different apoptotic mechanisms 
are activated in male and female brains after neonatal hypoxia-ischaemia. J Neurochem. 2006; 
96:1016–1027. [PubMed: 16412092] 
38. Johnston MV, Ishida A, Ishida WN, Matsushita HB, Nishimura A, Tsuji M. Plasticity and injury in 
the developing brain. Brain Dev. 2009; 31:1–10. [PubMed: 18490122] 
39. Leviton A, Blair E, Dammann O, Allred EN. The wealth of information conveyed by gestational 
age. J Pediatr. 2005; 146:123–127. [PubMed: 15644836] 
40. Chounti A, Hagglund G, Wagner P, Westbom L. Sex differences in cerebral palsy incidence and 
functional ability: a total population study. Acta Paediatr. 2013; 102:712–717. [PubMed: 
23551760] 
41. Scharfman HE, MacLusky NJ. Sex differences in the neurobiology of epilepsy: a preclinical 
perspective. Neurobiol Dis. 2014; 72(Pt B):180–192. [PubMed: 25058745] 
42. Akman O, Moshe SL, Galanopoulou AS. Sex-specific consequences of early life seizures. 
Neurobiol Dis. 2014; 72(Pt B):153–166. [PubMed: 24874547] 
43. Developmental Disabilities Monitoring Network Surveillance Year Principal I, Centers for Disease 
C, Prevention. Prevalence of autism spectrum disorder among children aged 8 years - autism and 
developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill 
Summ. 2014; 63:1–21.
44. Frazier TW, Georgiades S, Bishop SL, Hardan AY. Behavioral and cognitive characteristics of 
females and males with autism in the Simons Simplex Collection. J Am Acad Child Adolesc 
Psychiatry. 2014; 53:329–340. e1–e3. [PubMed: 24565360] 
45. Sandin S, Lichtenstein P, Kuja-Halkola R, Larsson H, Hultman CM, Reichenberg A. The familial 
risk of autism. JAMA. 2014; 311:1770–1777. [PubMed: 24794370] 
46. Zwaigenbaum L, Bryson SE, Szatmari P, Brian J, Smith IM, Roberts W, et al. Sex differences in 
children with autism spectrum disorder identified within a high-risk infant cohort. J Autism Dev 
Disord. 2012; 42:2585–2596. [PubMed: 22453928] 
47. Hiller RM, Young RL, Weber N. Sex differences in pre-diagnosis concerns for children later 
diagnosed with autism spectrum disorder. Autism. 2016; 20:75–84. [PubMed: 25717130] 
48. Mazina V, Gerdts J, Trinh S, Ankenman K, Ward T, Dennis MY, et al. Epigenetics of Autism-
related Impairment: Copy Number Variation and Maternal Infection. J Dev Behav Pediatr. 2015; 
36:61–67. [PubMed: 25629966] 
49. Himes KP, Simhan HN. Risk of recurrent preterm birth and placental pathology. Obstet Gynecol. 
2008; 112:121–126. [PubMed: 18591317] 
50. Wei SQ, Fraser W, Luo ZC. Inflammatory cytokines and spontaneous preterm birth in 
asymptomatic women: a systematic review. Obstet Gynecol. 2010; 116:393–401. [PubMed: 
20664401] 
51. Bastek JA, Brown AG, Anton L, Srinivas SK, D'Addio A, Elovitz MA. Biomarkers of 
inflammation and placental dysfunction are associated with subsequent preterm birth. J Matern 
Fetal Neonatal Med. 2011; 24:600–605. [PubMed: 20822327] 
52. Leviton A, Allred EN, Yamamoto H, Fichorova RN, Investigators ES. Relationships among the 
concentrations of 25 inflammation-associated proteins during the first postnatal weeks in the blood 
of infants born before the 28th week of gestation. Cytokine. 2012; 57:182–190. [PubMed: 
22133344] 
53. Johnson S, Hollis C, Kochhar P, Hennessy E, Wolke D, Marlow N. Autism Spectrum Disorders in 
Extremely Preterm Children. J Pediatr. 2010; 156:525–531. [PubMed: 20056232] 
54. Pietschnig J, Voracek M. One Century of Global IQ Gains: A Formal Meta-Analysis of the Flynn 
Effect (1909–2013). Perspect Psychol Sci. 2015; 10:282–306. [PubMed: 25987509] 
Appendix
Additional ELGAN Study Group Investigators include: Boston Children’s Hospital, Boston, 
MA: Janice Ware, PhD Taryn Coster, BA Brandi Hanson, PsyD Rachel Wilson, PhD Kirsten 
McGhee, PhD Patricia Lee, PhD Aimee Asgarian, PhD Anjali Sadhwani, PhD Tufts Medical 
Kuban et al. Page 11
J Pediatr. Author manuscript; available in PMC 2017 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Center, Boston, MA: Ellen Perrin, MD Emily Neger, MA Kathryn Mattern, BA Jenifer 
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Powers, RN Ann Foley, Ed M Brian Dessureau, PhD Molly Wood, PhD Jill Damon-Minow, 
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Chawarska, PhD Sophy Kim, PhD Susan Dieterich, PhD Karen Bearrs, PhD Wake Forest 
University Baptist Medical Center, Winston-Salem, NC: Nancy Peters, RN Patricia Brown, 
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Debbie Allred, PhD University Health Systems of Eastern Carolina, Greenville, NC: 
Stephen C. Engelke, MD Nancy Darden-Saad, BS, RN, CCRC Gary Stainback, PhD North 
Carolina Children’s Hospital, Chapel Hill, NC: Diane Warner, MD, MPH Janice 
Wereszczak, MSN, PNP Janice Bernhardt, MS, RN Joni McKeeman, PhD Echo Meyer, PhD 
Helen DeVos Children’s Hospital, Grand Rapids, MI: Steve Pastyrnak, PHD Julie Rathbun, 
BSW, BSN, RN Sarah Nota, BS Teri Crumb, BSN, RN, CCRC Sparrow Hospital, Lansing, 
MI: Madeleine Lenski, MPH Deborah Weiland, MSN Megan Lloyd, MA, EdS University of 
Chicago Medical Center, Chicago, IL: Scott Hunter, PhD Michael Msall, MD Rugile 
Ramoskaite, BA Suzanne Wiggins, MA Krissy Washington, MA Ryan Martin, MA Barbara 
Prendergast, BSN, RN Megan Scott, PhD William Beaumont Hospital, Royal Oak, MI: 
Judith Klarr, MD Beth Kring, RN Jennifer DeRidder, RN Kelly Vogt, PhD.
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Figure 1. 
Box-and-whisker plots of General Cognitive Ability scores (DAS-II), Language scores 
(OWLS) and Executive Function scores (DAS-II and NEPSY-II). All test Z-scores are 
adjusted to population norms. Key: darker gray is boys and lighter gray is girls. The central 
line in the box indicates the median (50th centile), while the top of the box indicates the 75th 
centile and the bottom of the box indicates the 25th centile. If ELGANs had the expected 
normal distribution of term-born children, the middle of the box would be at Z=0 and the 
upper and lower ends of the box would be at Z=1 and Z= −1, respectively. V=Verbal 
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Reasoning (DAS-II), NV=Nonverbal Reasoning (DAS-II), LC=Listening Comprehension 
(OWLS), OE=Oral Expression (OWLS), WM=Working Memory (DAS-II), AA=Auditory 
Attention (NEPSY-II), RS=Auditory Response Set (NEPSY-II), INI=Inhibition Inhibition 
(NEPSY-II), INS=Inhibition Switching (NEPSY-II), AS=Animal Sorting (NEPSY-II). 
Maximum N=874.
Kuban et al. Page 14
J Pediatr. Author manuscript; available in PMC 2017 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Kuban et al. Page 15
Table 1
Sample characteristics by sex (column percents)
Sex
Row
N
Girls
(n=428)
Boys
(n=446)
Maternal characteristics
Racial identity White 62 64 543
Black 26 26 226
Other 12 10 95
Hispanic Yes 12 8 86
Age, years < 21 15 11 113
21–35 65 69 586
> 35 20 20 175
Education, years ≤ 12 (high school) 42 40 347
> 12, < 16 25 22 198
≥ 16 (≥ college) 33 38 304
Single marital status Yes 41 39 348
Public insurance Yes 38 32 301
Newborn characteristics
Gestational age, weeks 23–24 18 23 180
25–26 46 45 396
27 36 32 298
Birth weight, grams ≤ 750 40 34 323
751–1000 43 44 379
> 1000 17 22 172
Birth weight Z-score < −2 8 4 51
≥ −2, < −1 18 9 116
≥ −1 74 87 707
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